Climb Bio, Inc. Files 8-K on Material Agreements
Ticker: CLYM · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1768446
Sentiment: neutral
Topics: material-agreement, financial-condition, corporate-update
TL;DR
Climb Bio (formerly Eliem) filed an 8-K on 3/25/25 covering material agreements and financials.
AI Summary
On March 25, 2025, Climb Bio, Inc. filed an 8-K report detailing a material definitive agreement, results of operations, and financial condition. The company, formerly known as Eliem Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides crucial updates on Climb Bio's material agreements and financial status, which are important for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting on material agreements and financial condition, not indicating immediate significant risk.
Key Players & Entities
- Climb Bio, Inc. (company) — Registrant
- Eliem Therapeutics, Inc. (company) — Former Company Name
- March 25, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 20 William Street, Suite 145, Wellesley Hills, Massachusetts 02481 (address) — Principal Executive Offices
FAQ
What specific material definitive agreement was entered into by Climb Bio, Inc. on or around March 25, 2025?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in the provided text.
What are the key aspects of Climb Bio, Inc.'s results of operations and financial condition reported in this 8-K?
The filing lists 'Results of Operations and Financial Condition' as an item, but the specific financial details or operational results are not detailed in the provided excerpt.
When did Climb Bio, Inc. change its name from Eliem Therapeutics, Inc.?
The filing states the date of the name change from Eliem Therapeutics, Inc. to Climb Bio, Inc. was February 19, 2019.
What is Climb Bio, Inc.'s Standard Industrial Classification (SIC) code?
Climb Bio, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where are Climb Bio, Inc.'s principal executive offices located?
Climb Bio, Inc.'s principal executive offices are located at 20 William Street, Suite 145, Wellesley Hills, Massachusetts 02481.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Climb Bio, Inc. (CLYM).